News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Zanidatamab is approved by US FDA based off Herizon BTC01
Nov 24, 2024, 04:47

Zanidatamab is approved by US FDA based off Herizon BTC01

Oncology Brothers shared a post on X:

“Zanidatamab (bispecific antibody against Her2) now US FDA approved for unresectable/metastatic HER2+ biliary tract cancer based off HerizonBTC01 – Single arm Ph2B study, 20 mg/kg IV Q2W – mDoR 14.9mos – mOS 15.5mos – AEs: Diarrhea, EF.”

Zanidatamab

Zanidatamab

More posts featuring Oncology Brothers.

antibody biliary tract Biliary tract cancer cancer diarrhea HER2 HerizonBTC01 metastatic OncoDaily Oncology Oncology Brothers US FDA Zanidatamab
Special Coverage
Blog
Nov 24, 2024, 04:47
Zanidatamab is approved by US FDA based off Herizon BTC01
Blog
Nov 24, 2024, 04:43
Preventive care is not just an option-it’s a priority - European Liver Patients'​ Association
Blog
Nov 24, 2024, 04:36
Learn about Cervical Cancer - National Institute for Cancer Research and Treatment
Blog
Nov 24, 2024, 04:30
James P. Crowley: New Paradigm for DNA Repair Research
Blog
Nov 24, 2024, 04:22
Dégi László Csaba: Honored to chair a landmark session at the European Cancer Summit 2024 alongside Isabel Rubio
Blog
Nov 24, 2024, 04:18
Susanna Greer: "Thank you for not smoking" - the inequity of this "ask."
Blog
Nov 24, 2024, 02:48
Vivek Subbiah: Honored to be named one of the 2024 Clarivate Highly Cited Researchers
Blog
Nov 24, 2024, 02:44
Miriam Mutebi: Collaborative faculty development workshop at KICC2024 by AORTIC- Africa and KESHO
Blog
Nov 24, 2024, 02:18
Alexis Vrachimis: Strong Cypriot Representation at the ECO Cancer Summit!
Blog
Nov 24, 2024, 02:10
Joanne Xiu: The complexity of biomarkers associated with Anti-PD-1/L1 Therapy Outcomes
Insight
Nov 24, 2024, 00:54
UCLA study uncovers how aggressive brain tumor evades treatment and highlights a promising new strategy
Insight
Nov 24, 2024, 00:46
November 2024 Tip Sheet of Sylvester Comprehensive Cancer Center